Pharvaris

$19.65 0.00% ($0.00)

Get ready to invest

About Pharvaris

Pharvaris B.V. operates as a clinical-stage company. The Company focuses on the discovery and development of novel oral B2-receptor antagonists for the treatment of patients. Pharvaris serves customers in the Netherlands and Switzerland.

Popular Stocks	Price	Change
AMC Entertainment AMC	$18.84 8.41%	8.41%
AT&T T	$27.31 0.48%	0.48%
AMD AMD	$131.93 3.62%	3.62%
Nvidia NVDA	$259.03 3.86%	3.86%
FuelCell FCEL	$4.58 5.18%	5.18%
Micron Technology MU	$92.87 4.61%	4.61%
Ford F	$24.38 3.22%	3.22%
Apple AAPL	$169.8 1.89%	1.89%
NIO NIO	$29.61 4.33%	4.33%